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Chronic rhinosinusitis (CRS) is an inflammatory condition that affects up to 12% of the
human population in developed countries. Previous studies examining the potential role
of the sinus bacterial microbiota within CRS infections have found inconsistent results,
possibly because of inconsistencies in sampling strategies. The aim of this study was
to determine whether the sinus microbiome is altered in CRS and additionally if the
middle meatus is a suitable representative site for sampling the sinus microbiome.
Swab samples were collected from 12 healthy controls and 21 CRS patients, including
all eight sinuses for CRS patients and between one and five sinuses for control
subjects. The left and right middle meatus and nostril swabs were also collected.
Significant differences in the sinus microbiomes between CRS and control samples were
revealed using high-throughput 16S rRNA gene sequencing. The genus Escherichia
was over-represented in CRS sinuses, and associations between control patients and
Corynebacterium and Dolosigranulum were also identified. Comparisons of the middle
meatuses between groups did not reflect these differences, and the abundance of
the genus Escherichia was significantly lower at this location. Additionally, intra-patient
variation was lower between sinuses than between sinus and middle meatus, which
together with the above results suggests that the middle meatus is not an effective
representative sampling site.
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INTRODUCTION
Chronic rhinosinusitis (CRS) is characterized by persistent inflammation of the nose and the
paranasal sinuses with symptoms including nasal obstruction or nasal discharge, in addition
to facial pain or pressure and a reduction in the sense of smell (Fokkens et al., 2012). To be
distinguished from acute sinusitis, symptoms must exceed 12 weeks in duration without complete
resolution. The prevalence of CRS is between 4.5 and 12% in developed countries (DeConde
and Soler, 2016), resulting in substantial societal morbidity, with costs related to healthcare,
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lost working days (Bhattacharyya, 2009) and decreased
productivity estimated to surpass $12.8 billion dollars per annum
in the United States alone (DeConde and Soler, 2016).
Current medical and surgical treatments are often very
broadly applied across the patient population. Maximal
medical therapy (MMT) is recommended as initial treatment
and may include nasal saline irrigations, topical and oral
corticosteroids and antibiotics. Patients who have an
inadequate response to medical treatment may be offered
functional endoscopic sinus surgery (FESS), a surgical
procedure aiming to restore sinus ventilation and function
by widening the ostia of sinus cavities (Khalil and Nunez,
2006; Patel et al., 2017) and reducing inflammatory load
(Bassiouni et al., 2012). In a quality of life study, surgical
intervention in patients with high symptom scores was a
more effective treatment strategy than ongoing medical
treatment (Patel et al., 2017). Improved understanding of the
pathophysiology of CRS should lead to more targeted treatment
options.
The presence or absence of nasal polyps has been a traditional
way to phenotype CRS patients into two groups; CRS with
nasal polyposis (CRSwNP) and CRS without nasal polyposis
(CRSsNP). There is evidence to support distinct immunologic
endotypes, including T helper (Th) 1-driven pathways for
CRSsNP and Th2-driven pathways for CRSwNP (Van Zele et al.,
2006; Beswick et al., 2017), however, there are currently no
independent methods of treatment in practice.
Originally, the sinuses were assumed to be sterile in healthy
patients, but laden with bacteria in CRS patients (Meltzer
et al., 2004; Ramakrishnan et al., 2013b). Early research
into the pathophysiology of CRS focused on a model where
inflammation was hypothesized to be driven by bacterial
infection (Hoggard et al., 2017). Later, other infectious agents,
including viruses and fungi, were proposed to be involved,
but evidence to support these hypotheses is lacking (Boase
et al., 2013; Hamilos, 2014). Non-infectious factors, including
anatomic and genetic abnormalities, innate immune deficiencies,
asthma, allergy, aspirin sensitivity, and biofilm formation, have
all been considered as modulators of disease establishment or
severity (Lam et al., 2015; Ramakrishnan and Frank, 2015;
Anderson et al., 2016).
More recently, research into the pathophysiology of CRS
has focused on the role of the entire microbial community
residing in the sinuses (Abreu et al., 2012; Cleland et al.,
2016). This is due to a shift away from culture-based methods
of bacterial identification and advances in culture-independent
16S rRNA gene sequencing. With an increased understanding
of interactions within microbial communities, a “dysbiosis”
mechanism has been proposed as modulating inflammation in
diseased sinuses (Bordin et al., 2016). The hypothesis suggests
that externally influenced changes in the sinonasal microbiome
can result in dysbiosis, i.e., a shift from a “normal” or “healthy”
microbial community structure, and that this shift may be
responsible for the initiation or maintenance of CRS (Lam et al.,
2015; Jervis Bardy and Psaltis, 2016). One proposed model
suggests that loss of nasal epithelial integrity allows for an
increased permeability of the microbial community through the
superficial layer, initiating an immune response from the host
(Hoggard et al., 2017; Valera et al., 2017).
Diversity measures used in 16S rRNA gene sequencing studies
can serve as useful markers of disease. For example, changes in
alpha diversity, which is the diversity of species within a sample,
have been observed in inflammatory airway diseases, including
chronic obstructive pulmonary disease (COPD), asthma and
allergic rhinitis (Ege et al., 2011; Garcia-Nuñez et al., 2014; Lynch
et al., 2014). Reduced bacterial diversity in CRS patients has been
reported in studies with relatively low numbers of participants
(Abreu et al., 2012; Choi et al., 2014; Biswas et al., 2015), while one
study reported increased bacterial diversity (Aurora et al., 2013).
Other studies found no differences in alpha diversity (Cleland
et al., 2016), including one of the largest studies to date with
70 CRS and 31 control participants (Ramakrishnan and Frank,
2015). As such it is still unclear whether alpha diversity is a useful
marker of the CRS disease state.
Bacteria from the genera Staphylococcus, Propionibacterium,
and Corynebacterium are prevalent in the sinuses of CRS patients
reported across multiple studies, however, these genera are also
ubiquitous in healthy subjects. No single bacterial species has
been reported to be consistently higher or lower in relative
abundance in CRS subjects between studies. For example, Abreu
et al. found enrichment of C. tuberculostearicum in CRS patients
(Abreu et al., 2012), while Aurora et al. found higher relative
abundances of C. accolens (Aurora et al., 2013). Observations
of depleted species in CRS include Bacteroidetes spp., Prevotella
spp. (Choi et al., 2014), Lactobacillus spp. (Abreu et al., 2012),
Peptoniphilus spp., Propionibacterium acnes (Boase et al., 2013),
Acinetobacter johnsonii, andCorynebacterium confusum (Cleland
et al., 2016). Differences in primers used and regions of the 16S
rRNA gene targeted make it difficult to directly compare results
between studies at the species level. However, in a recent meta-
analysis of published 16S rRNA gene sequence data, Mackenzie
et al. suggested that Burkholderia and Propionibacteriummay be
gatekeepers that stabilize the healthy bacterial community, as the
removal of these genera from healthy datasets resulted in more
fragmented networks that were potentially more susceptible to
disturbance (WagnerMackenzie et al., 2017). Still, the connection
between the sinonasal microbiome and CRS has not yet been
defined unequivocally (Anderson et al., 2016; Hoggard et al.,
2017).
One possible reason for contrasting results in different
studies is methodological differences, including variant sampling
techniques and choice of sampling site. The sinuses can only be
accessed through FESS (Fokkens et al., 2012) meaning there are
limited opportunities to sample from the disease site, particularly
in non-CRS controls. However, the middle meatus, an area of
the nasal cavity that accepts drainage from the maxillary, anterior
ethmoid, and frontal sinuses (Feazel et al., 2011), can be sampled
without surgical intervention. As such, the middle meatus is the
most commonly sampled site in studies of the sinus microbiome
(Stephenson et al., 2010; Feazel et al., 2012; Aurora et al., 2013;
Boase et al., 2013; Ramakrishnan et al., 2013a,b; Biswas et al.,
2015; Joss et al., 2015; Kim et al., 2015; Ramakrishnan and Frank,
2015; Cleland et al., 2016; Hauser et al., 2016; Ivanchenko et al.,
2016; Kaspar et al., 2016; Willis et al., 2016). One small study
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of eight CRS patients found the middle meatus to be broadly
representative of the sinuses (Ramakrishnan et al., 2017), but this
has not been explored inmore detail. Furthermore, the possibility
of substantial intra-patient variation, or the variation between
individual sinuses within a single patient (Joss et al., 2015), is
another possible confounding factor.
The primary objective of this study was to test the hypothesis
that the sinonasal microbiome of CRS patients is distinctly
different to those found in healthy control sinuses. We aimed
to avoid confounding factors such as sampling site by sampling
from as many sites as possible from each participant. This design
also enabled the secondary objective of this study, which was to
test the hypothesis that a swab from the middle meatus would
obtain a representative sample of the entire sinus microbiome
and to examine the degree of intra-patient variation across the
sinuses in both CRS and control subjects.
MATERIALS AND METHODS
Patient Recruitment
Study participants were recruited from the Sydney-based
practices of Otorhinolaryngologists, Nicholas Stow, Justin Kong,
Yuresh Naidoo, and Martin Forer, between June 2015 and
January 2017. The study protocol was approved by the Northern
Sydney Local Health District Human Research Ethics Committee
under approval number HREC/10/HAWKE/145. Two groups
of patients were informed about the study and invited to
participate: firstly, those requiring endoscopic sinus surgery on all
paranasal sinuses for the treatment of CRS (with or without nasal
polyposis) and, secondly, controls who were undergoing sinus
surgery for non-sinusitis indications and who had no clinical
or radiological evidence of sinusitis. If the patient indicated
interest in participating in the study, the surgeon obtained
written informed consent. Diagnosis of CRS was made based on
the diagnostic criteria of the EPOS guidelines (Fokkens et al.,
2012). Clinical data for each patient were collected, including
demographics, SNOT-22 symptom scores (Kennedy et al., 2013),
asthma status, and surgical history. Patients who had taken
antibiotics or oral corticosteroids in the month prior to surgery
were excluded from the study.
Sample Collection
General anesthesia was administered and the nasal cavity
was prepared by infiltration with a local anesthetic solution,
most commonly 1% lignocaine and 1:80,000 adrenaline, then
placement of pledgets soaked with topical vasoconstrictor
solution, most commonly 1:2,000 adrenaline. Modern techniques
of FESS, using a microdebrider (Medtronic) and through-cutting
instruments (Storz), were used to preserve mucosa while creating
the largest possible sinus cavities by enlargement of natural ostia.
As each sinus was opened, a sterile Copan Amies Transport
swab (Interpath Services) was introduced into the sinus, under
endoscopic guidance. Each swab was passed through a mixing
cannula, then into the nose, to protect the swab tip from
contamination from other sites. Each swab was placed in a sterile
Eppendorf tube and stored at −80◦C until DNA extraction. For
the CRS group, a total of 11 swabs were collected (from each
of the following sites on the left and right side: middle meatus,
maxillary sinus, ethmoid sinus, sphenoid sinus, and frontal sinus,
as well as a swab from the right nostril). For the control group,
swabs were collected from the right nostril, right and left middle
meatus and each sinus opened at surgery. Overall, this meant
the design of the study was nested such that multiple locations
were sampled within each patient and each patient was nested by
health status.
DNA Extraction
The genomic extraction of all swabs collected was performed
using PowerSoil DNA Isolation kit (Mo Bio). Samples were
removed from storage at−80◦C and the swab heads were shaved,
using a scalpel blade, from the metal body and prepared using an
alternate method proposed by the manufacturer. This included
combining the addition of solution C2 and C3 into one step and
omitting the addition of solution C4. DNA was stored at −20◦C
in 60 µL elution buffer until further processing.
Library Preparation and Sequencing
Amplification of the 16S rRNA gene V3–V4 region was
performed using primers designed to anneal to the 338F and
806R positions of the Escherichia coli 16S rRNA gene, carried
out in a two-stage protocol. Primers for PCR Stage One included
the 16S rRNA gene priming regions, a 0–3 nucleotide spacer for
increased diversity between sequence clusters (Wu et al., 2015)
and partial Illumina sequencing adaptors (Table S1). PCR Stage
Two primers contained an overlap of the adaptor region from
PCR Stage One, a sample barcode (8 nt) and a flow cell adaptor
region compatible with the Illumina MiSeq (Table S2).
All amplifications were performed in 50 µL reactions using
Taq Core PCR Kit (Qiagen); 1X buffer, dNTPs at 250µM,
1.25U Taq polymerase, and 0.5µM each of both forward and
reverse primers (Table S1). The first amplification step was
performed under the following thermal cycling conditions: one
initial denaturation step at 95◦C for 3min; 20 cycles at 95◦C
for 15 s, at 55◦C for 30 s and at 72◦C for 40 s; and extension at
72◦C for 3min; and a hold step at 4◦C. A cleanup procedure was
performed on the resultant amplicons (>200 bp) using a 0.8X
volume of magnetic AMPure XP beads (Beckman Coulter) to
purify the amplicons from free primers and primer dimer species,
following the manufacturer’s specifications.
In the second amplification step, the maximum amount of the
purified product of the first PCR (27.5 µL) was used as template
in a reaction which included 0.5µM each of the enrichment_i7
and enrichment_i5 primers (see Table S2) in a total volume of 50
µL. Unique combinations of indexes from i7 and i5 enrichment
primers were used for sample barcoding. Reactions were subject
to thermal cycling of one initial denaturation step at 95◦C for
3min; 15 cycles at 95◦C for 15 s, at 55◦C for 30 s and at 72◦C
for 60 s; and extension at 72◦C for 3min; and a hold step at
4◦C. Positive (E. coli DNA) and negative controls were included
with every PCR run. The ZymoBIOMICS microbial community
DNA standard (Zymo Research) (hereafter called the mock
community) consisting of eight bacterial and two yeast species
was amplified as a sequencing control to assess consistency across
sequencing runs, and to ensure that the PCR and sequencing
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 February 2018 | Volume 8 | Article 57
Copeland et al. CRS Microbiome
conditions used were able to accurately capture a community
of known composition. A cleanup procedure on the resulting
amplicons was performed as described above and the final DNA
concentrations of the purified products were assayed using the
Qubit Fluorometer 2.0 (Thermo Fisher Scientific) as per the
manufacturer’s instructions. Samples were combined into two
pools with approximately equal concentrations of 16S rRNA gene
amplicons from each sample, with the mock community and
PCR negative controls included in each sequencing run, and
underwent a final cleanup procedure as described above to obtain
a final concentration of approximately 5 nM. Both libraries were
sequenced on an Illumina MiSeq using the Reagent Kit V3
with 600 cycles (Illumina). Libraries were denatured and diluted
according to the manufacturer’s recommendations and loaded at
a concentration of 12 pM with 5% PhiX control.
Sequence Analysis
Sequences were demultiplexed with Phylosift 1.0.1 (Darling et al.,
2014) and merged using FLASh 1.2.11 (Magoc and Salzberg,
2011) with default settings, except for a minimum overlap of
80 and maximum of 140 bases. Merged sequences were quality
filtered using the fastq_filter command in USEARCH v9.0.2132
(Edgar and Flyvbjerg, 2015) with the fastq_maxee setting at 2 to
remove sequences with more than 1 expected error.
The mock community sequences only were analyzed using
BLAST 2.6.0 (Altschul et al., 1997) against a local database of the
known community sequences. Only the best hit was retrieved for
each sequence and the identity of the best hit was used to assign
each sequence to a member of the mock community. The relative
proportion of each species obtained in each sequencing run were
compared to the expected proportions from the DNA mixture
and the log2 fold-change from the expected relative abundance
was calculated.
The QIIME 1.9.1 software package (Caporaso et al., 2010) was
then used for Operational Taxonomic Unit (OTU) picking, using
the pick_open_reference_otus.py workflow script. Chimeric
sequences were identified using the identify_chimeric_seqs.py
command with the usearch61 method and removed with the
filter_otus_from_otu_table.py script. Taxonomy was assigned
using the SINA 1.3.1 alignment and classification tool (Pruesse
et al., 2012) with the SILVA REF NR 99 ssu database (released
13th December 2017), accessed from the SILVA website1.
The data were rarefied to 6,000 sequences per sample
for all downstream analyses using the single_rarefaction.py
script. The OTU table was filtered to include only OTUs
that were present in at least 5% (n = 12) of samples during
determination of differential abundance of OTUs and taxonomic
groups between groups of samples. For tests of differential
abundance or correlation to metadata, in order to account
for repeated sampling from individuals counts of OTUs or
taxa from samples from the same individual were summed,
followed by normalization of total counts per individual to
1 using the collapse_samples.py script. For tests at higher
taxonomic levels, the OTU table was collapsed per taxonomic
level, followed by collapsing counts per individual as described
1arb-silva.de/download/arb-files
above. Tests for differential abundance (by health status, nasal
polyp status within the CRS group and by sinus within the
control and CRS groups) were performed at each level using
the group_significance.py script and the default Kruskal-Wallis
test with Benjamini-Hochberg FDR correction to account for
multiple testing. Tests were performed on sinus samples and
middle meatus samples separately. Correlation of the OTU
relative abundance level and SNOT-22 scores was performed
using the observation_metadata_correlation.py script. Further
analyses were then carried out in R 3.4.0 (Ihaka and Gentleman,
1996). The alpha diversity metric employed (Shannon) considers
both the number and the distribution of species (Shannon)
(Shannon, 1948) at a local site. Weighted Unifrac (Lozupone and
Knight, 2005) was used as the beta diversity metric to compare
overall similarities or dissimilarities of the whole microbial
community structure between local sites. Alpha diversity, beta
diversity, and Principal Coordinates Analysis (PCoA) were
calculated with the Phyloseq 1.20.0 (McMurdie and Holmes,
2013) and Vegan 2.4 (Oksanen et al., 2017) packages. Plots were
produced using the dplyR 0.7.0 (Wickham et al., 2017) and
ggplot2 2.2.1 (Wickham, 2016) packages. For comparisons of
alpha diversity, statistical analyses were performed using the lme4
1.1 (Bates et al., 2015) and lemrTest 2.0 (Kuznetsova et al., 2016)
R packages and the ANOVA function, with a model specifying
repeated measures from individual patients as a random variable.
PERMANOVA, implemented in the adonis function of the Vegan
package, was used to determine differences in beta diversity
between groups of interest. Tests for homogeneity of group
dispersions and differences between groups were carried out with
the betadisper and permutest functions in the Vegan package.
The intra-patient weighted and unweighted unifrac distances
between the sphenoid and middle meatus of the healthy group
and the CRS group and the intra-patient distances comparing
the middle meatus samples with nostril and sinuses were tested
using ANOVA. For all statistical tests, significance was defined as
p < 0.05. Designation of genera as anaerobic was done manually
based on literature searches. All genera known to be anaerobic or
facultative anaerobic were selected and the relative abundances
plotted.
In order to examine potential host to microbe and microbe
to microbe interactions which may influence the disease state,
network analysis was performed using the extended local
similarity analysis (eLSA) pipeline (Xia et al., 2011). eLSA
enabled identification of statistically significant patterns in the
co-occurrence of bacterial OTUs, alpha diversity, and disease
state across sinus samples from 32 patients. Thereby, teasing out
from a vast background of correlations, the interactions that most
likely represent relationships that are meaningful within a disease
context. Each sinus sample was designated as a replicate within
its respective patient and missing values (representing 0.4% of
the dataset) were linearly interpolated using the linear fill missing
function as employed by Needham et al. (2013). Filtering criteria
included removal of pairwise interactions that occurred across
<10% of the sample replicates, and each remaining interaction
was subjected to 500 permutations to estimate p-values (the
probability of a false positive) and q values (the probability of
a false negative). Interactions where p ≥ 0.001 and q ≥ 0.01
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were excluded to reduce the risk of Type I and Type II errors.
Resultant data included all statistically significant co-occurrence
values, which was prepared for visualization by first assigning
local Similarity (LS) values of pairwise interactions to edges, then
plotted into a network using the edge-weighted spring embedded
function in Cytoscape 3.0 software package (Shannon et al.,
2003).
RESULTS
A total of 31 subjects were included in the study, including 12
healthy controls and 21 CRS patients. 57% (n = 12) of CRS
patients had nasal polyps. Patient characteristics were collected
and are displayed in Table S3, with a total of 287 swabs collected
(indicated in Table S4).
Sequencing Data
Quality filtered sequence data from the two sequencing runs was
deposited in the European Nucleotide Archive under accession
numbers ERR2145113 and ERR2145112. Additionally, data is
available on the Qiita website2 under study ID 11622. A
total of 18,377,078 sequences passed quality filtering steps and
chimera removal across 292 samples, with a median coverage of
45,911 sequences per sample. Analysis of the mock community
sequences from the two sequencing runs showed that 98% of
sequences passing quality filters were within 97% similarity to
the reference sequences from the mock community. Across the
two sequencing runs, similar abundances were achieved for the
mock community members, all within −0.5 to 0.5 log2 fold
change from the expected abundance (Figure S1). Coverage of
three PCR and DNA extraction process negative controls was
low (329, 542, and 3,255 sequences after quality filtering) and
these sequences were dominated by the common skin bacterial
genera Corynebacterium and Staphylococcus. Given that these
genera are also likely to be in sinus and nasal samples, we
did not filter any taxa from the data. Instead we required
sequence coverage of more than or equal to 6,000 sequences for
inclusion in the sample data. Based on rarefaction analysis, all
samples were rarefied to 6,000 sequences per sample for further
analysis.
Comparison of Sinus Microbial
Communities Between CRS and Controls
To determine if alpha diversity is a suitable marker of disease,
differences in Shannon diversity were examined between the
control and the disease group. When considering sinus cavities
only, there was no significant difference (ANOVA; p > 0.05),
however, when the CRS group was split into CRSwNP and
CRSsNP, both control and CRSwNP sinuses had significantly
lower diversity than CRSsNP (Figure 1).
Discrimination of total control and CRS communities was
explored through beta diversity analyses. Pairwise distances
between samples were calculated using the weighted unifrac
metric and visualized as PCoA plots (Figure 2). CRS samples
overlapped substantially with controls, but a significant
2http://qiita.microbio.me
FIGURE 1 | Boxplot of Shannon diversity. (A) Diversity in sinus cavities from
CRS subjects separated by the absence (CRSsNP) or presence (CRSwNP) of
nasal polyps and control subjects. Significant differences indicated by *
(ANOVA, p < 0.05).
PERMANOVA result suggested that the communities differed
between control and CRS sinuses. The size of this effect was
indicated by the R2-value of the test, which showed that health
status (i.e., CRS vs. controls) accounted for 7% of the variation
in the dataset (p < 0.001), while the largest amount (51.5%)
was due to inter-individual variation (p < 0.001). CRS samples
visually appeared more dispersed, which can result in a false
significant PERMANOVA score. However group dispersion was
not significantly different between CRS and controls (betadisp
test p > 0.05), indicating that the significant result was due to
a difference in community structure, as opposed to dispersion.
A significant difference in beta diversity between CRS subtypes
CRSwNP and CRSsNP was detected (PERMANOVA p <
0.001), however in this case the beta-dispersion was significantly
different between groups.
Differentially Abundant Microbes in CRS
Are Correlated with Disease State and
Diversity
The microbial communities in the sinuses of all subjects were
represented primarily by the phyla Firmicutes, Actinobacteria,
Proteobacteria, and Bacteroidetes. In the CRS group,
Proteobacteria were significantly more abundant overall
(Kruskal Wallis, FDR adjusted p < 0.01) (See Figure 3). At the
level of genus, only Escherichia was significantly different with
higher relative abundance in CRS (Kruskal-Wallis test with
FDR adjusted p-value < 0.01) (Figure 4). This was reflected at
the OTU level, where five OTUs classified as Escherichia were
significantly more abundant in the CRS group (Kruskal-Wallis
test with FDR adjusted p-values < 0.05). We note that the
taxonomic assignment according to the SILVA taxonomy is listed
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 February 2018 | Volume 8 | Article 57
Copeland et al. CRS Microbiome
FIGURE 2 | PCoA of weighted Unifrac distances. Samples from sinus cavities only are included, and ellipses represent 95% confidence intervals.
FIGURE 3 | Average relative abundance of phyla in CRS and control subjects. Values are averages across all sinus samples per patient. Percentages were calculated
from rarefied data. Phyla that were significantly different in relative abundance between CRS and controls are marked with * (Kruskal-Wallis, FDR corrected p < 0.05).
as Escherichia-Shigella. For the sake of simplicity, we refer to this
genus simply as Escherichia.
In the control group, the Actinobacteria were significantly
more abundant (Kruskal Wallis, FDR adjusted p < 0.01). No
genera were significantly more abundant in the controls, however
one OTU classified as Corynebacterium (OTU 410908) was.
When comparing CRSwNP to CRSsNP, no OTUs or taxa were
significantly different.
Network analysis revealed 16 OTUs with significant eLSA
scores for correlation to disease status (Figure 5). The abundance
of six OTUs were negatively correlated with the CRS disease state,
three of which were Dolosigranulum, two were Corynebacterium,
and one Staphylococcus. Corynebacterium and Dolosigranulum
OTUs were positively correlated with each other. The 10 OTUs
positively correlated with CRS consisted of eight OTUs classified
as Escherichia and two OTUs from the Burkholderiaceae
family (genera Roseateles and Pelomonas), which were all
positively correlated with each other. OTUs from the genera
Corynebacterium and Escherichia were also identified in the
differential abundance results described above (from Kruskal
Wallis tests), however only five OTUs (all Escherichia) were
concordant across the two analyses.
Of the other categories included in the network analysis,
including age, sex, smoking status, and history of asthma, only
SNOT-22 scores and Shannon Diversity correlated with disease.
Disease status was positively correlated with Shannon diversity,
which was in turn positively correlated with several OTUs
from taxa that are strict and facultative anaerobes, including
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FIGURE 4 | Average relative abundance of OTUs per patient colored by genus. Only sinus samples were included, and OTUs with average relative abundance of
<1% were excluded. Percentages were calculated from rarefied data. Genera that were significantly different in relative abundance between CRS and controls are
marked with * (Kruskal-Wallis, FDR corrected p < 0.05).
FIGURE 5 | Network of OTUs associated with disease status, and strong significant correlations to other OTUs. Networks were calculated using extended local
similarity analysis and plotted using the Cytoscape3 software package. Nodes are colored by genus taxonomic assignment, and metadata category nodes are
colored red. Glow behind nodes indicates the relationship to disease status (blue, positive correlation; red, negative). Black lines indicate positive correlations, and the
length indicates the strength (short, strong; long, weak). Red lines indicate negative correlations and the length indicates the strength in the opposite direction to black
(long, strong; short, weak).
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Finegoldia, Anaerococcus, Peptoniphilus, and Lactobacillus.
Smoking status was negatively correlated with 6 Staphylococcus
OTUs and positively correlated with 10 OTUs classified as
Fusobacteria (n = 2), Prevotella (n = 4), Dialister (n = 2),
Campylobacter (n = 1), Slakia (n = 1), Escherichia (n = 1), and
Citrobacter (n= 1) (Figure S2).
Strict and facultative anaerobic genera (designated as such
via manual literature searches) that accounted for >1% average
relative abundance per patient included Anaerococcus, Dialister,
Finegoldia, Porphyromonas, Parvimonas, and Prevotella. CRS
patients 7, 10, 14, 17, and 43 had high levels of these anaerobic
genera (between 10 and 80% relative abundance) across all or
most sinuses that yielded data. Most other CRS patients had high
levels in one or more sinuses, with the exception of patients
26, 27, 28, and 42 (Figure S3). Half of the control patients had
low (<10%) relative abundance of these anaerobic genera in all
sinuses sampled (Figure S4).
Correlation of Bacterial Taxa to Symptom
Severity
To determine whether the abundance of particular bacterial
taxa were associated with increased or decreased severity of
disease symptoms, Spearman’s correlations were calculated for
both OTUs and genera against SNOT-22 scores. SNOT-22 scores
range from 0 to 110, with higher scores associated with more
severe symptoms. Nineteen OTUs had significant correlations
(FDR corrected p < 0.05) to SNOT-22 scores, with the strength
of correlations ranging from−0.52 to 0.61.
Only one OTU (OTU 410908, Corynebacterium) was
negatively correlated to SNOT-22 scores. A scatter plot with
linear regression line overlaid is shown in Figure 6A. No
genera were negatively correlated to SNOT22 scores. Positive
correlations to SNOT-22 scores were found for 18 OTUs, nine of
which were assigned to Escherichia (n= 9), The other nine OTUs
were present at very low relative abundance and only showed
higher relative abundance in a limited number of samples (see
Figure S5 for plots of every OTU with a significant correlation).
At the genus level, only Escherichia was positively correlated
(0.61), as shown in Figure 6B.
Is the Middle Meatus Representative of
Sinus Microbial Communities?
To determine whether the more easily accessible middle meatus
samples were representative of an individual’s sinuses, we
calculated intra-patient weighted unifrac distances for middle
meatus vs. sinuses (MMvS) and compared those to sinuses vs.
sinuses distances (SvS) (Figure 7A). CRS patients had a small but
significant difference between MMvS and SvS distances, where
sinuses were more similar to each other than the middle meatus
was to the sinuses.
To explore this further, we looked for genera that were
consistently differentially abundant between middle meatus and
sinus samples. No genera were identified in control patients,
while in CRS patients Escherichia was significantly lower in the
middle meatus (Kruskal-Wallis test with FDR adjusted p-value
< 0.01). The average relative abundance of Escherichia in sinuses
and middle meatus samples is shown in Figure 7B. Tests at the
OTU and genus level for differential abundance between CRS and
control groups onmiddle meatus samples only did not detect any
significant differences.
Additionally, the intra-patient distances were compared
between the control and CRS groups to determine whether
CRS is associated with more disparate microbial communities
between sites within an individual. A trend of higher between
site intra-patient distances (weighted unifrac) was observed
between microbial communities within the same individual in
CRS compared to controls (Figure 8), which approached but
did not reach the significance cut-off (p = 0.06). Inter-patient
variability was significantly higher than intra-patient variability
(p < 0.0001).
DISCUSSION
The concept of “dysbiosis” in the sinus cavities during
CRS has gained traction due to observations of shifts in
bacterial community structures, delivered by 16S rRNA
sequencing technologies (Bordin et al., 2016). However, several
methodological limitations, including substantial variation in the
native microbiome between individuals, limitations in obtaining
larger samples sizes for control subjects and the influence of
other disease-modulators, have hindered efforts to confirm this
hypothesis (Anderson et al., 2016; Lee et al., 2016). This is further
compounded by the known issues of differences in primer bias
and regions of the 16S rRNA gene analyzed across studies.
Additionally, the existence of spatial variation of the microbiome
between sinus cavities has not yet been adequately addressed,
which has implications for optimal microbiome sampling in CRS
and sinus microbiome research.
CRS Was Associated with Changes in
Some Diversity Measures
A number of diseases have been shown to correlate with
increased (Liu et al., 2013) or decreased (Kostic et al., 2015)
microbiome diversity, indicating that a change in alpha diversity
can be a useful marker of the disease state. Whether alpha
diversity is a marker of CRS is unclear from previous studies
(Abreu et al., 2012; Aurora et al., 2013; Choi et al., 2014; Biswas
et al., 2015; Ramakrishnan and Frank, 2015; Cleland et al.,
2016). We saw significant trend of higher alpha diversity in
CRSsNP compared to controls in the sinus cavities. We also
saw a significant difference between CRS subtypes, however
given that the large overlap between these groups the biological
significance of this finding is unclear. Network analysis provided
further evidence for an increase in diversity and/or evenness in
the disease state, with a significant positive correlation between
Shannon diversity and CRS (Figure 5). Given the disparity in
results between our own and previous studies, it is likely that
larger sample sizes and consistency of sampling site will be
needed to definitively determine whether alpha diversity is an
indicator of disease state in CRS.
Weighted unifrac was used as the beta diversity metric to
compare the microbial community structure between samples.
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FIGURE 6 | SNOT-22 vs. relative abundance for (A) one Corynebacterium OTU with a negative correlation, and (B) the genus Escherichia with a positive correlation.
Plots are overlaid with a linear regression line and shading indicating 95% confidence interval. Individual patient samples are indicated with color. Rarefied data were
used to generate the plot.
FIGURE 7 | Differences between middle meatus and sinus microbial communities. (A) Intra-patient distances between middle meatus and sinus (MMvS) and sinus
and sinus (SvS) samples for weighted Unifrac distances. Significant difference is indicated with * (ANOVA, p < 0.05). (B) Average relative abundance of the genus
Escherichia in middle meatus samples (top panels), and sinus samples (bottom panels).
PERMANOVA analysis indicated that disease status (CRS or
control) was a significant factor, suggesting that the community
profiles differ and providing further evidence to support the
hypothesis that a shift in sinus microbial communities is
associated with CRS (Stephenson et al., 2010; Biswas et al., 2015;
Ramakrishnan et al., 2015; Cleland et al., 2016; Cope et al.,
2017). Studies of the microbiome in other sites of the airways
have similarly found microbial community shifts associated with
disease. For example, infectious exacerbations of COPD lead
to changes in the bacterial microbiome, including increases in
Moraxella spp. (Wang et al., 2016; Wilkinson et al., 2017).
CRS Was Correlated with the Presence
and Abundance of Specific Bacterial Taxa
In this study, a higher relative abundance of oneCorynebacterium
OTU was consistently found in healthy sinuses, when comparing
to the CRS sinuses. Network analysis showed that two other
Corynebacterium OTU were correlated to a reduced SNOT-
22 score, in addition to directly negatively correlated to CRS
disease. This is consistent with a recent survey of postoperative
success in CRS subjects undergoing FESS, which found an inverse
relationship between Corynebacterium and SNOT-22 score (Jain
et al., 2017), supporting a possible probiotic nature of some
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FIGURE 8 | Intra vs. inter-individual weighted Unifrac distances in CRS and
control subjects. Inter-individual distances were significantly higher than
intra-individual distances, indicated with *(ANOVA, p < 0.05). A trend of higher
intra-individual distances in CRS subjects was observed, but only approached
significance (ANOVA, p = 0.06).
species within the genus. Other observations in previous studies
have also shown higher abundance of the genus Corynebacterium
in controls compared to CRS. For example, Cleland et al. found
that C. confusum was correlated to healthy individuals (Cleland
et al., 2016). Not all members of the genus may show the same
interaction, as C. accolens and C. tuberculostearicum have been
shown to be enriched in CRS sinuses (Abreu et al., 2012; Aurora
et al., 2013).
The abundance of three Dolosigranulum OTUs were
negatively correlated to the CRS health state. This genus is
dominant in nasal communities (Biswas et al., 2015) and the
middle meatus samples of healthy patients (Ramakrishnan
et al., 2013b), while also present at low abundance in the middle
meatus of CRS patients (Kim et al., 2015). Dolosigranulum
has been found to co-colonize with Corynebacterium species,
including C. propinquum (Kaspar et al., 2016), and Yan et al.
reported OTUs assigned to Dolosigranulum were top predictors
of Staphylococcus aureus carriage (Yan et al., 2013). These
genera have been reported in other areas of the upper airways,
correlated with a decreased risk of Streptococcus pneumoniae
colonization in the upper airways (Pettigrew et al., 2012) and
acute ear infections in children that had no reported antibiotic
use for the previous 6 months (Laufer et al., 2011).
Propionibacterium are widely detected in the sinuses in both
healthy and CRS subjects (Feazel et al., 2012; Aurora et al., 2013;
Boase et al., 2013), and were identified as a possible “Gatekeeper”
taxa in healthy sinuses (Wagner Mackenzie et al., 2017).We
did not detect Propionibacterium here, most likely because of a
knownmismatch with the penultimate base in the reverse primer
with the 16S rRNA gene in P. acnes (Gohl et al., 2016). We
did attempt to create our 16S rRNA gene sequencing libraries
using a polymerase (Kapa Hifi, Kapa Biosciences) which has been
shown to be capable of editing this base and capturing the genus
Propionibacterium (Gohl et al., 2016). However, for reasons we
were unable to discern, we were unable to amplify any of our
samples with this particular polymerase.
Staphylococcus has been commonly implicated in CRS
pathology (Choi et al., 2014; Biswas et al., 2015; Ramakrishnan
et al., 2015; Cleland et al., 2016). However, this genus
encompasses multiple species, including Staphylococcus
epidermidis and S. aureus, which have been associated
with healthy individuals and those with CRS, respectively
(Stephenson et al., 2010; Feazel et al., 2012; Boase et al.,
2013). Since it is difficult to accurately classify OTUs to the
species level based on fragments of the 16S rRNA gene, it is
challenging to draw specific conclusions from a relative increase
or decrease in this genus. In this study, Staphylococcus did not
correlate to disease severity and was not significantly higher
in relative abundance in the disease group: in fact, one OTU
was negatively correlated to disease. Another Staphylococcus
OTU was negatively correlated to Shannon diversity (which
was positively correlated to disease) and additionally negatively
correlated to CRS-associated genera (Figure 5), suggesting a
potential benefit of some Staphylococcus spp. in the healthy sinus
cavity.
The “health-associated” taxa identified here could provide
a protective environment against pathogens either passively,
through competition for space or resources, or actively through
secretion of antimicrobial compounds (Psaltis and Wormald,
2017). Alternatively, these genera could be the most susceptible
to changes that occur in the sinus environment as a result of the
CRS disease process.
Members of the genus Anaerococcus exhibited positive
correlations to Shannon diversity (Figure 5) which was positively
correlated to the disease state. Anaerococcus, along with
Finegoldia and Peptinophillus (also correlated to increased
Shannon diversity) are anaerobic. Anaerobic genera overall were
observed to be more prevalent in CRS including those mentioned
above andDialister, Porphyromonas, Parvimonas, and Prevotella.
Anaerobic taxa such as Peptoniphilus, Anaerococcus, and
Prevotella have been reported as abundant taxa in CRS
(Stephenson et al., 2010; Bassiouni et al., 2015; Biswas et al., 2015;
Joss et al., 2015; Kim et al., 2015; Cleland et al., 2016; Ivanchenko
et al., 2016). Conditions within the sinus cavities are not usually
anaerobic, and the expansion of anaerobic bacteria in CRS may
be indicative of environmental changes to the sinuses as a result
of disease pathology (Brook, 2006).
In our study, the genus Escherichia was significantly more
abundant across CRS patients when compared to controls
and also positively correlated to increased symptom severity
scores. Network analyses further confirmed the direct and
strongly positive correlation of several Escherichia OTUs to
CRS (Figure 5). The link between an inflammatory environment
and subsequent proliferation of E. coli has been observed in
the gut, where the release of reactive nitrogen species as an
immune response can be utilized by these organisms for cellular
respiration and growth (Scales et al., 2016). Thus, an increase
in relative abundance of Escherichia in CRS may be related to
the characteristic inflammation of the sinuses, and may result in
exacerbation of the inflammatory host response.
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Microbial Communities in CRS with and
Without Nasal Polyps
The presence of nasal polyps was associated with lower
Shannon diversity when compared to CRSsNP sinuses, however
no other significant differences were found in terms of
bacterial community composition. A previous study found no
differences in community structure between disease sub-types
(Ramakrishnan et al., 2015), while a more recent study found a
higher relative risk of nasal polyposis associated with microbial
communities dominated by the Corynebacteriaceae family (Cope
et al., 2017). So far, there is not a strong indication from the
literature that these different CRS subtypes are associated with
different microbial communities.
Reflections on Dysbiosis in CRS
While characterization of the CRS microbiome has led to
inconsistent findings between studies, the dysbiosis hypothesis
has been widely suggested as a mechanism involved in
CRS pathogenesis (Ramakrishnan and Frank, 2015; Anderson
et al., 2016). Dysbiosis occurs following a breakdown of the
network of bacteria, leading to community-wide alterations
in the microbiota (Petersen and Round, 2014; Jervis Bardy
and Psaltis, 2016; Wagner Mackenzie et al., 2017). This
could include “keystone species,” or microbes that normally
maintain a stable and interactive community, cohabitating with
a consortium of low abundance bacteria in the healthy state
(Wagner Mackenzie et al., 2017). The removal of these key
species may have a significant effect on the community, for
example, by allowing the overgrowth of potentially pathogenic
species.
Our study supports the idea of bacterial community collapse
in CRS. We identified different potentially “health-associated”
OTUs within the genera Dolosigranulum and Corynebacterium.
Further investigation is required to elucidate any influence
on health, including a possible role in increased resilience
of the community, and direct interactions with the host
immune system. In accordance with the dysbiosis hypothesis, the
depletion or reduction of these species may allow for the growth
of normally rare taxa that promote or contribute to a prolonged
inflammatory state, for example bacteria from the genus
Escherichia (Steimle et al., 2016). Conversely, changes in “health-
associated” taxa may occur as a secondary effect; that these
taxa may only be sensitive to the prolonged inflammatory state,
or sensitive to changes in potential opportunistic pathogenic
species. The directionality of this effect cannot be determined
from this study. Caution should also be applied before identifying
particular organisms as “pathogenic,” as their presence alone
does not necessarily indicate disease. The increased abundance
of particular taxa in CRS or with disease severity may be due to
the loss of community structure, for example, antagonism with
keystone species or loss of major network interactions between
bacterial members.
The role of the eukaryotic community was not explored in
this study. Fungi have been observed via culturing and molecular
methods in previous studies, however no significant differences
in the richness or prevalence of fungus between CRS and controls
has been observed so far (Boase et al., 2013; Cleland et al., 2014a;
Zhao et al., 2018). Other potential mediators of disease which
were not explored in this study include the viral community
(including bacteriophage) (Lee et al., 2015; Rowan et al., 2015)
and the host response (Lam et al., 2015).
While changes in CRS communities have been confirmed, it
is unknown whether these changes are sufficient to initiate CRS,
to exacerbate or prolong an inflammatory state, or whether they
exist as a non-deleterious consequence of the disease (Hoggard
et al., 2017). Part of the dysbiosis mechanism may involve loss
of the Sino-nasal epithelial layer integrity, with bacteria (or other
pathogens) and their metabolites activating the immune system,
further aggravating and prolonging inflammation (Bordin et al.,
2016). The future use of animal models to explore the influence
of both disease and health associated organisms identified here
could be an effective means to establish potential functional
roles in chronic sinus disease. Additionally, investigation into the
potential for reduction in symptom severity by the inoculation
of health-associated taxa could provide a viable alternative
to the current ineffective use of antibiotics (Cleland et al.,
2014b).
Variation Within the Sinus Cavities and
Potential for Sampling Error in the Middle
Meatus
The large effects of inter-individual variation in microbial
communities have been well documented in CRS studies (Biswas
et al., 2015; Joss et al., 2015; Kim et al., 2015; Ramakrishnan
et al., 2017), in healthy individuals (Kaspar et al., 2016) as well
as in microbiome studies of other body sites (Huttenhower
et al., 2014). In this study, inter-subject differences explained the
largest proportion of variation within the bacterial communities
(Figure 8).
Comparison of the variation in microbial communities
across sinuses within an individual has been limited to studies
without a healthy group. Joss et al. determined the existence
of substantial variation in some individuals with CRS (Joss
et al., 2015), and Ramakrishnan et al. found varying levels
of similarity when comparing communities at genus level
(Ramakrishnan et al., 2017). Our study design is unique in
that multiple sinuses in both CRS and control groups were
sampled, enabling examination of the intra-patient variation
in both CRS and control groups. As expected, intra-patient
variation was significantly lower than inter-patient variation
and there was a trend of higher intra-patient variability in the
CRS group. This result only approached significance, potentially
because of the comparatively low number of comparisons in the
control group. If this trend is real, it suggests that the microbial
communities in the sinuses within an individual diverge during
CRS, which has implications for selecting a representative
sampling site.
Due to the increased accessibility of the middle meatus in
comparison to the sinus sites, it is important to consider if
sampling from this site will obtain a representative snapshot
of the resident bacteria. Within an individual, the bacterial
communities from sinuses were significantlymore similar to each
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other than they were to communities from the middle meatus,
albeit a small difference (Figure 7A). Importantly, the differences
observed in the sinuses at both OTU and genus level with health
status were not reflected in the corresponding middle meatal
samples. Specifically, middle meatal samples underestimated the
relative abundance of the genus Escherichia (Figure 7B), which
as demonstrated here may have an important association with
CRS. While broadly similar in taxonomic composition, the
middle meatus does show differences to the sinus microbial
communities, as has been seen previously (Ramakrishnan et al.,
2017). Therefore, the middle meatus does not accurately capture
the CRS sinus microbiome.
Although variation does exist between sinuses within an
individual, no consistent differences were detected between
different types of sinuses. In order to sample a representative
microbial sinus community in CRS, our data supports the
recommendation to sample in at least one site, but preferably
more, within the sinus cavities.
CONCLUSION
We have identified an association of OTUs from the genera
Corynebacterium andDolosigranulum with non-CRS sinuses and
an increase in the genus Escherichia in CRS. The middle meatus
alone does not provide a representative sample of the CRS sinus
microbiota, as differences in taxa abundance identified in the
sinus cavities between groups were not detected from middle
meatus samples. Future studies of the sinus microbiota should
include samples from at least one, and ideally multiple sinuses to
obtain a more accurate understanding of the sinus microbiome
in CRS.
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